Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.58 |
| ▸ | NPY1R | P25929 | 7/20 | 0.58 |
| ▸ | NPY2R | P49146 | 5/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.58 |
| ▸ | GNPAT | O15228 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.51 |
| ▸ | FNTA | P49354 | 3/20 | 0.48 |
| ▸ | FNTB | P49356 | 3/20 | 0.48 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23142771 | 1.00 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL30051461 | 1.00 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652148 | 1.00 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL30051400 | 1.00 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652154 | 1.00 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29628174 | 0.99 | GNPAT (0.57) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL30692730 | 0.99 | GNPAT (0.57) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL10381527 | 0.99 | GNPAT (0.57) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652149 | 0.98 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652144 | 0.98 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022128940-A1 | POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | GENEPEP (FR) | 2022-06-23 | — | — | WO | claimed |
| US-20240084068-A1 | POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | GENEPEP (FR) | 2024-03-14 | — | — | US | disclosed |
| WO-2022128940-A1 | POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | GENEPEP (FR) | 2022-06-23 | — | — | WO | disclosed |
| EP-4011932-A1 | POLYMER COMPOUND WITH PENDANT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | Genepep (FR) | 2022-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240084068-A1 | POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | VIP, PSAP, NGLY1 | NPY4R 935/4885NPY1R 914/4885NPY2R 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.